Eysz
Eysz develops a digital health platform using eye-movement analysis to assess brain health, aiding personalized care for neurological disorders.
Founded
2018Eysz develops a digital health platform using eye-movement analysis to assess brain health, aiding personalized care for neurological disorders.
Eysz was founded with the mission to revolutionize neurological care by providing a digital health platform that leverages eye-movement analysis to measure disease progression, intervention efficacy, and side effects. This innovative approach aims to assist clinicians in developing personalized care plans for patients with chronic neurological disorders. Eysz addresses the significant economic burden and stagnant patient outcomes associated with the lack of reliable biomarkers in neurological diseases, focusing on improving diagnostic accuracy and treatment personalization.
Notable affiliated individuals and investors include experts in neurology and digital health, although specific names are not provided. Eysz has achieved significant milestones in developing its platform, which has the potential to transform how neurological disorders are managed globally. By providing objective data to clinicians, Eysz aims to enhance patient outcomes and reduce the economic impact of neurological diseases, which currently cost $1.7 trillion in the US and Europe alone.
Companies similar to Eysz include neuroFit, Nile, Aural Analytics and NeuroVision Imaging.
Eysz was founded in 2018.
Eysz's headquarters is located in Piedmont, CA, US.
Eysz's most recent funding round was for $1M (USD) in June 2023.
As of Jun 15, 2023, Eysz has disclosed funding of $3.9M (USD). Undisclosed round amounts are excluded.
Eysz has 7 employees as of Feb 5, 2024.
NeuroVision Imaging
neurovision.com
